| Composition: General practitioners |
|
| Mean (SD) |
13.1 (5.5) |
| Median (Q1, Q3) |
12.0 (10.3, 14.1) |
| Composition: Ophtalmologists |
|
| Mean (SD) |
1.7 (0.8) |
| Median (Q1, Q3) |
1.6 (1.2, 2.0) |
| Composition: Surgeons |
|
| Mean (SD) |
2.2 (1.2) |
| Median (Q1, Q3) |
2.0 (1.4, 2.7) |
| Composition: Multidisciplinary practices |
|
| Mean (SD) |
7.7 (4.2) |
| Median (Q1, Q3) |
6.8 (5.5, 9.3) |
| Composition: Therapists |
|
| Mean (SD) |
45.2 (10.4) |
| Median (Q1, Q3) |
47.3 (42.5, 51.3) |
| Composition: Internists |
|
| Mean (SD) |
6.4 (2.5) |
| Median (Q1, Q3) |
6.2 (4.9, 7.6) |
| Composition: Orthopedics |
|
| Mean (SD) |
1.9 (0.9) |
| Median (Q1, Q3) |
1.8 (1.3, 2.4) |
| Composition: Psychologists and psychotherapists |
|
| Mean (SD) |
6.6 (2.6) |
| Median (Q1, Q3) |
6.3 (5.0, 7.9) |
| Composition: Other disciplines |
|
| Mean (SD) |
12.6 (4.5) |
| Median (Q1, Q3) |
11.6 (9.8, 14.6) |
| Composition: Urologists |
|
| Mean (SD) |
1.0 (0.6) |
| Median (Q1, Q3) |
1.0 (0.6, 1.3) |
| Composition: Rehabilitation facilities |
|
| Mean (SD) |
0.8 (0.6) |
| Median (Q1, Q3) |
0.8 (0.3, 1.2) |
| Composition: Hospitals |
|
| Mean (SD) |
0.9 (0.7) |
| Median (Q1, Q3) |
0.8 (0.5, 1.2) |
| Composition: Proportion of care-dependent persons in cluster |
|
| Mean (SD) |
11.1 (3.0) |
| Median (Q1, Q3) |
10.5 (8.8, 12.8) |
| Composition: Number of providers in cluster |
|
| Mean (SD) |
823.4 (981.5) |
| Median (Q1, Q3) |
499.0 (273.0, 998.5) |
| No. of Comorbidities |
|
| Mean (SD) |
1.9 (0.2) |
| Median (Q1, Q3) |
1.8 (1.7, 2.0) |
| COC Asthma |
|
| Mean (SD) |
69.3 (5.5) |
| Median (Q1, Q3) |
69.3 (65.7, 73.6) |
| SECON Asthma |
|
| Mean (SD) |
83.2 (3.9) |
| Median (Q1, Q3) |
83.5 (80.6, 86.0) |
| UPC Asthma |
|
| Mean (SD) |
80.7 (3.8) |
| Median (Q1, Q3) |
80.8 (78.3, 83.6) |
| COC COPD |
|
| Mean (SD) |
74.5 (5.3) |
| Median (Q1, Q3) |
75.0 (70.8, 78.4) |
| SECON COPD |
|
| Mean (SD) |
84.4 (4.0) |
| Median (Q1, Q3) |
84.7 (81.5, 87.7) |
| UPC COPD |
|
| Mean (SD) |
83.3 (4.0) |
| Median (Q1, Q3) |
83.7 (80.7, 86.3) |
| COC Dementia |
|
| Mean (SD) |
81.2 (4.1) |
| Median (Q1, Q3) |
81.6 (78.7, 84.2) |
| SECON Dementia |
|
| Mean (SD) |
89.4 (2.7) |
| Median (Q1, Q3) |
89.5 (87.5, 91.4) |
| UPC Dementia |
|
| Mean (SD) |
88.0 (2.9) |
| Median (Q1, Q3) |
88.4 (86.4, 90.1) |
| COC Diabetes |
|
| Mean (SD) |
78.6 (5.8) |
| Median (Q1, Q3) |
79.2 (74.7, 83.2) |
| SECON Diabetes |
|
| Mean (SD) |
87.9 (4.2) |
| Median (Q1, Q3) |
88.6 (85.3, 91.3) |
| UPC Diabetes |
|
| Mean (SD) |
85.8 (4.3) |
| Median (Q1, Q3) |
86.2 (82.8, 89.1) |
| COC Heart Failure |
|
| Mean (SD) |
72.1 (5.4) |
| Median (Q1, Q3) |
72.5 (68.4, 76.2) |
| SECON Heart Failure |
|
| Mean (SD) |
85.4 (3.7) |
| Median (Q1, Q3) |
85.6 (82.9, 88.2) |
| UPC Heart Failure |
|
| Mean (SD) |
82.0 (4.0) |
| Median (Q1, Q3) |
82.3 (79.3, 85.0) |
| Asthma: Prevalence |
|
| Mean (SD) |
3.9 (1.2) |
| Median (Q1, Q3) |
3.8 (3.2, 4.6) |
| Asthma: Spirometry |
|
| Mean (SD) |
36.5 (8.2) |
| Median (Q1, Q3) |
36.1 (30.5, 41.9) |
| Asthma: Inhalative medication |
|
| Mean (SD) |
45.8 (7.6) |
| Median (Q1, Q3) |
45.5 (40.3, 51.2) |
| Asthma: ICS |
|
| Mean (SD) |
26.9 (7.1) |
| Median (Q1, Q3) |
26.5 (22.1, 31.2) |
| Medication: PRISCUS |
|
| Mean (SD) |
20.3 (2.7) |
| Median (Q1, Q3) |
20.3 (18.2, 22.2) |
| Medication: Beta-Blocker after myocardial infarction |
|
| Mean (SD) |
56.2 (3.4) |
| Median (Q1, Q3) |
56.5 (54.4, 57.9) |
| Medication: ACE-inhibitor upon hypertension and renal insufficiency a |
|
| Mean (SD) |
47.5 (3.9) |
| Median (Q1, Q3) |
47.9 (45.3, 49.9) |
| Medication: ACE-inhibitor upon heart failure |
|
| Mean (SD) |
49.0 (4.1) |
| Median (Q1, Q3) |
49.1 (46.5, 51.5) |
| Medication: Beta-blocker upon asthma |
|
| Mean (SD) |
20.5 (4.0) |
| Median (Q1, Q3) |
20.2 (17.8, 22.9) |
| Medication: Eletrolyte check upon diuretics |
|
| Mean (SD) |
21.6 (5.2) |
| Median (Q1, Q3) |
21.5 (18.5, 24.9) |
| Medication: Polypharmacy |
|
| Mean (SD) |
33.4 (3.6) |
| Median (Q1, Q3) |
33.4 (30.9, 35.6) |
| Ambulatory care sensitive cases |
|
| Mean (SD) |
3.3 (0.6) |
| Median (Q1, Q3) |
3.3 (2.9, 3.7) |
| COPD: Prevalence |
|
| Mean (SD) |
9.2 (2.1) |
| Median (Q1, Q3) |
9.1 (7.7, 10.5) |
| COPD: Inhalative medication |
|
| Mean (SD) |
43.0 (4.2) |
| Median (Q1, Q3) |
43.1 (40.3, 45.9) |
| COPD: Acute inpatient treatment |
|
| Mean (SD) |
2.2 (0.5) |
| Median (Q1, Q3) |
2.1 (1.8, 2.5) |
| COPD: Respiratory therapy |
|
| Mean (SD) |
5.0 (2.3) |
| Median (Q1, Q3) |
5.1 (3.7, 6.5) |
| COPD: influenca vaccination |
|
| Mean (SD) |
9.3 (2.6) |
| Median (Q1, Q3) |
8.7 (7.5, 10.5) |
| COPD: Specific beta-blocker therapy |
|
| Mean (SD) |
34.7 (4.2) |
| Median (Q1, Q3) |
34.8 (31.7, 37.6) |
| COPD: Specific anticholinergic therapy |
|
| Mean (SD) |
19.7 (3.5) |
| Median (Q1, Q3) |
19.8 (17.2, 21.9) |
| COPD: Oral corticosteroids |
|
| Mean (SD) |
10.9 (2.8) |
| Median (Q1, Q3) |
11.0 (8.8, 12.7) |
| CVD: Prevalence hypertension |
|
| Mean (SD) |
62.5 (5.5) |
| Median (Q1, Q3) |
61.5 (58.3, 66.6) |
| CVD: Medication for hypertension |
|
| Mean (SD) |
5.4 (1.6) |
| Median (Q1, Q3) |
5.0 (4.2, 6.2) |
| CVD: Prevalence heart failure |
|
| Mean (SD) |
1.9 (1.1) |
| Median (Q1, Q3) |
1.7 (1.1, 2.5) |
| CVD: Echocardiography upon heart failure |
|
| Mean (SD) |
6.7 (6.1) |
| Median (Q1, Q3) |
4.9 (2.6, 9.1) |
| CVD: 12-lead ECG upon heart failure |
|
| Mean (SD) |
10.9 (7.2) |
| Median (Q1, Q3) |
9.8 (6.4, 13.7) |
| CVD: ACE-inhibiter upon heart failure |
|
| Mean (SD) |
58.8 (3.9) |
| Median (Q1, Q3) |
59.0 (56.3, 61.4) |
| CVD: Beta-blocker upon heart failure |
|
| Mean (SD) |
49.0 (4.7) |
| Median (Q1, Q3) |
49.3 (45.8, 52.0) |
| CVD: Anticoagulant upon artrial fibrillation and heart failure |
|
| Mean (SD) |
45.7 (3.7) |
| Median (Q1, Q3) |
45.8 (43.6, 48.1) |
| CVD: Referral to cardiologist upon heart failure |
|
| Mean (SD) |
11.5 (8.2) |
| Median (Q1, Q3) |
10.2 (5.8, 15.5) |
| CVD: Acute inpatient treatment of heart failure |
|
| Mean (SD) |
13.4 (3.3) |
| Median (Q1, Q3) |
13.0 (11.2, 15.1) |
| CVD: Apoplexy treatment in stroke unit |
|
| Mean (SD) |
1.6 (1.2) |
| Median (Q1, Q3) |
1.6 (0.5, 2.4) |
| CVD: Platelet aggregation inhibitor upon stable chronic coronary heart disease |
|
| Mean (SD) |
21.0 (4.8) |
| Median (Q1, Q3) |
21.4 (17.3, 24.7) |
| CVD: Statins upon coronary heart disease |
|
| Mean (SD) |
30.6 (4.8) |
| Median (Q1, Q3) |
31.3 (27.7, 34.3) |
| CVD: Anti-hypertensive therapy upon coronary heart disease and hypertension |
|
| Mean (SD) |
86.1 (1.5) |
| Median (Q1, Q3) |
86.3 (85.1, 87.1) |
| Dementia: Prevalence |
|
| Mean (SD) |
4.2 (1.1) |
| Median (Q1, Q3) |
4.0 (3.5, 4.7) |
| Dementia: B12 and TSH |
|
| Mean (SD) |
1.2 (1.2) |
| Median (Q1, Q3) |
1.0 (0.4, 1.7) |
| T2D: Prevalence |
|
| Mean (SD) |
22.1 (4.8) |
| Median (Q1, Q3) |
20.7 (18.5, 25.9) |
| T2D: HbA1c |
|
| Mean (SD) |
60.0 (8.0) |
| Median (Q1, Q3) |
60.7 (54.9, 66.2) |
| T2D: Ophtalmological examination |
|
| Mean (SD) |
29.3 (4.8) |
| Median (Q1, Q3) |
29.1 (26.2, 32.2) |
| T2D: Fundus examination |
|
| Mean (SD) |
16.5 (3.8) |
| Median (Q1, Q3) |
16.7 (14.6, 18.6) |
| T2D: Triglycerides and cholesterol |
|
| Mean (SD) |
17.5 (6.7) |
| Median (Q1, Q3) |
17.4 (12.7, 21.6) |
| T2D: Hypertension, nepropathy and A |
|
| Mean (SD) |
63.7 (4.4) |
| Median (Q1, Q3) |
63.8 (61.2, 66.4) |
| T2D: Serum-creatinin |
|
| Mean (SD) |
53.6 (7.6) |
| Median (Q1, Q3) |
53.1 (48.2, 59.2) |
| Osteoarthritis: Prevalence |
|
| Mean (SD) |
27.0 (3.8) |
| Median (Q1, Q3) |
26.8 (24.2, 29.3) |
| Osteoporosis: Prevalence |
|
| Mean (SD) |
10.9 (2.2) |
| Median (Q1, Q3) |
10.6 (9.4, 12.2) |
| Prevention: Influenca vaccination |
|
| Mean (SD) |
7.7 (2.7) |
| Median (Q1, Q3) |
7.0 (5.9, 8.7) |
| Prevention: Mammography |
|
| Mean (SD) |
2.2 (2.4) |
| Median (Q1, Q3) |
2.1 (-0.5, 4.1) |
| Prevention: Faecal occult blood test |
|
| Mean (SD) |
1.9 (0.5) |
| Median (Q1, Q3) |
1.9 (1.6, 2.2) |
| Prevention: Men’s cancer screening |
|
| Mean (SD) |
6.6 (1.5) |
| Median (Q1, Q3) |
6.6 (5.6, 7.6) |
| Prevention: Skin-cancer screening |
|
| Mean (SD) |
0.5 (0.3) |
| Median (Q1, Q3) |
0.5 (0.3, 0.7) |
| Depression: Prevalence |
|
| Mean (SD) |
11.3 (2.7) |
| Median (Q1, Q3) |
11.1 (9.7, 12.8) |
| Depression: Anti-depressive pharmacotherapy |
|
| Mean (SD) |
36.2 (4.1) |
| Median (Q1, Q3) |
36.1 (33.6, 38.3) |